Novartis Preserves Vasella in Aspic
Daniel Vasella, chairman and chief executive of Novartis, should not have accepted a $78m payment, according to th Financial Times (here).
Mr Vasella “has agreed to continue to make available his knowhow...
The Real Agenda of GSK’s New Blog and Why the Authors’ Identities are Cloaked
The world's second largest drug company, GSK, has followed the lead of the world's most trusted drug company (J&J) and entered the blogosphere and Twitterdom.The blog, American Health: More Than Medicine,...
New “New Media” Trick for Pharma Marketers
Pity the poor FDA! Despite its use of social and other "New" media, the FDA is not equipped to keep up with the new technology that allows unethical pharmaceutical marketers to...
Botox BS Piled Higher and Deeper
Have you seen the latest ads for Botox? The tag line is "freedom of expression..." The ads go on to say "Don't hold back! Express it all!" The copy writers certainly...
Risk-First DTC: A Tactic to Overcome Resistance
First there was Risk-Free DTC (see "DTC without the Risk"). Now there is Risk-First DTC!Before I get into that, there's a related story I'd like to review about how risk is...
Google’s Wacky Wiki is Whack! Pharma Should Demand Ability to Block It!
Have you heard of sidewiki? Sidewiki is Google's new browser sidebar that "enables you to contribute and read helpful information alongside any web page. It is available as a feature in...
Buzz is NOT regulated by FDA
It seems that Cialis will be back at the Super Bowl with a 60-second commercial that may cost as much as $4.8 million (see "Impotence drug returns to Super Bowl ...
Social Media Listening by Pharma: Do the Ends Justify the Means?
This morning, I read with interest "The Value of Social Media Listening" by Alexandra Fulford, a ZS Business Consultant based in Zurich, Switzerland,
Alex focused on the "value in listening and doing...
The Pharma Social Media Pioneering Era is Over! Long Live the Pharma Mobile App...
Today I chaired CBI's Social Media Compliance Strategies and Benchmarking Summit in Philadelphia. In my opening comments I declared that the pharma social media pioneer era is over. Here's a draft...
According to Follower Wonk, I Have More Followers in Common with Pfizer Than Other...
This morning I learned about "Follower Wonk," a neat Twitter application that creates Venn diagrams showing the overlap among followers of up to three different Twitter accounts. It does other stuff,...
